StockGlow

Akebia Therapeutics, Inc. (AX9.F)

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

1.15+0.07%Healthcare
Compare AX9.F with
StockGlow Score
34
Leaning Bearish
BearishBullish
1 year ago-63.6%

The outlook

Akebia Therapeutics, Inc. currently reads as leaning bearish based on mixed vs its moving averages, 16% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendMixed vs its moving averages
52-week range16% of the way from its 52-week low to high
Market cap
$307.6M
52-wk high
3.25
52-wk low
0.74
50-day avg
0.97
200-day avg
1.20
Trailing P/E
—

Similar stocks

AZG2.FAcacia Research Corporation$3.76-2.59%BO1.FBioCryst Pharmaceuticals, Inc.$8.03-2.48%BST.DEBastei Lübbe AG$6.30-3.96%24H.FHansa Biopharma AB (publ)$3.04-4.46%BST.FBastei Lübbe AG$6.20-2.52%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy